Transcatheter closure of fontan fenestrations using the Amplatzer septal occluder: initial experience and follow-up.
We have recently used the Amplatzer septal occluder to close Fontan fenestrations. Between June 1998 and December 1999, 13 patients underwent transcatheter occlusion of their Fontan fenestrations. Systemic blood flow decreased significantly without a concomitant decrease in pulmonary blood flow. All residual shunts detectable by oximetry were at sites separate from those into which occlusion devices were implanted. One patient developed severe tricuspid regurgitation following the procedure requiring surgical removal of the device. At the last follow-up, all patients were doing well clinically. There were no shunts detectable through or around the devices by echocardiography. Our experience indicates that the location of the fenestration within the Fontan baffle is critical to avoiding device interference with other intracardiac structures. The Amplatzer septal occluder offers an effective means of transcatheter closure of Fontan baffle fenestrations. Although more experience is needed, our current follow-up data suggest that long-term outcomes will be favorable. Cathet. Cardiovasc. Intervent. 51:301-304, 2000.
Cowley
C G
CG
Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Badran
S
S
Gaffney
D
D
Rocchini
A P
AP
Lloyd
T R
TR
D000328:Adult; D006328:Cardiac Catheterization; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D018729:Fontan Procedure; D006439:Hemodynamics; D006801:Humans; D019736:Prostheses and Implants; D012086:Reoperation